# FDA Inspection 1105950 - Aesica Pharmaceuticals GmbH - August 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/888139f3-ba68-4645-990a-129c24334c99
Source feed: FDA_Inspections

> FDA Inspection 1105950 for Aesica Pharmaceuticals GmbH on August 30, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1105950
- Company Name: Aesica Pharmaceuticals GmbH
- Inspection Date: 2019-08-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277716 - 2023-08-31](https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/d6a6b8a4-3554-44f8-9ad9-9207b154e97e)
- [FDA Inspection 994783 - 2016-12-02](https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/0456755c-0478-4307-a780-5b38b7237190)
- [FDA Inspection 887354 - 2014-06-20](https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/f6df76d7-b881-4945-8a88-53c7310b1cf1)
- [FDA Inspection 759166 - 2011-11-08](https://www.keypedia.com/records/fda_inspections/aesica-pharmaceuticals-gmbh/86ee1d6d-9727-4361-9265-c27791a4e289)

Company: https://www.keypedia.com/companies/aesica-pharmaceuticals-gmbh/84c48ef1-0bd9-41c7-b955-9bb5b443909a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c